Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06230783 · ClinicalTrials.gov registry record

Speech Pattern Evaluation and Analysis for Knowledge of AD

A clinical trial of Wisconsin Alzheimer's Disease Research Center and Wisconsin Registry for Alzheimer's Prevention, sponsored by University of Wisconsin, Madison.

Recruiting
Registry status
165
Enrollment target
1
Study location

NCT06230783 is a study of Wisconsin Alzheimer's Disease Research Center and Wisconsin Registry for Alzheimer's Prevention that is actively recruiting participants, run by University of Wisconsin, Madison. The registered enrollment target is 165 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06230783, a study of Wisconsin Alzheimer's Disease Research Center and Wisconsin Registry for Alzheimer's Prevention, is actively recruiting participants, sponsored by University of Wisconsin, Madison.

RECRUITING
Registry status
165 participants
Enrollment target
1
Study location

Study Summary

The goal of this observational study is to validate changes in speech as a measure of cognition in individuals at increased risk of Alzheimer's disease and related dementias (ADRD). This study aims to clarify how speech may be affected by Alzheimer's disease. Participants will complete speech collection sessions and a survey at home using an iPad. Participants can expect to be in the study for 3 years.

Interventions

  • OTHER TalkTracker

Study Locations (1)

Wisconsin

  • University of Wisconsin - Madison

Trial Details

FieldValue
Enrollment Target 165 participants
Start Date 2025-01-22
Est. Completion 2029-02

Sponsor

University of Wisconsin, Madison

1,039 total trials

What the Registry Record Tells You About NCT06230783

The ClinicalTrials.gov registry entry for NCT06230783 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 165 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Wisconsin Alzheimer's Disease Research Center appearing as the primary indexed condition, and to 1 intervention - of which TalkTracker is the first listed.

NCT06230783 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.

Frequently Asked Questions

What is clinical trial NCT06230783 about?

NCT06230783 is a clinical study titled "Speech Pattern Evaluation and Analysis for Knowledge of AD". The goal of this observational study is to validate changes in speech as a measure of cognition in individuals at increased risk of Alzheimer's disease and related dementias (ADRD). This study aims to clarify how speech may be affected by Alzheimer's disease. Participants will complete speech colle...

What is the current status of trial NCT06230783?

This trial is currently recruiting. The enrollment target is 165 participants. The study started on 2025-01-22. Estimated completion is 2029-02.

What conditions does trial NCT06230783 study?

This clinical trial studies the following conditions: Wisconsin Alzheimer's Disease Research Center, Wisconsin Registry for Alzheimer's Prevention.

What interventions are being tested in trial NCT06230783?

The interventions under investigation include: TalkTracker (OTHER).

Who is sponsoring clinical trial NCT06230783?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06230783 being conducted?

This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.